Product Information
GEMFIBROZIL 600 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1034 per EA under NDC 65862062405. Its NADAC has been published 399 times since Nov 7, 2018.
Strength
600 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862062405
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GEMFIBROZILApproval Type
Generic (ANDA)
FDA Application
ANDA202726On Market Since
9/16/2015
Pharmacological Classes
Price Statistics
The NADAC for GEMFIBROZIL 600 MG TABLET has been published 399 times since Nov 7, 2018, and over the history we have for it it has risen 18.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1034 per EA |
|---|---|
| All-time high | $0.1158 (Sep 11, 2019) |
| All-time low | $0.0871 (Nov 20, 2024) |
| 52-week high | $0.1075 |
| 52-week low | $0.1005 |
| Median price | $0.1057 |
| Average price | $0.1050 |
| Largest weekly change | -18.6% (Apr 17, 2024) |
| Weeks tracked | 399 |
| Tracking since | Nov 7, 2018 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GEMFIBROZIL 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GEMFIBROZIL 600 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1034 per EA (NDC 65862062405), effective Jun 24, 2026.
How has the price of GEMFIBROZIL 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for GEMFIBROZIL 600 MG TABLET has risen 18.1%. It has been tracked across 399 weekly CMS publications since Nov 7, 2018.
What are the highest and lowest recorded NADAC prices for GEMFIBROZIL 600 MG TABLET?
Since Nov 7, 2018, the NADAC for GEMFIBROZIL 600 MG TABLET has ranged from a low of $0.0871 (Nov 20, 2024) to a high of $0.1158 (Sep 11, 2019), with a median of $0.1057 per EA.
Are there cheaper alternatives to GEMFIBROZIL 600 MG TABLET?
Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GEMFIBROZIL 600 MG TABLET, is $0.0891 per EA — about 14% below GEMFIBROZIL 600 MG TABLET.
Who manufactures GEMFIBROZIL 600 MG TABLET?
GEMFIBROZIL 600 MG TABLET (NDC 65862062405) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification